tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

EPIX Stock Latest News

ESSA Pharma Inc. Explores Strategic Alternatives After Clinical Trial Termination
Company AnnouncementsESSA Pharma Inc. Explores Strategic Alternatives After Clinical Trial Termination
1M ago
EPIX
ESSA Pharma Reports Q2 2025 Financial Results and Strategic Review
PremiumCompany Announcements
ESSA Pharma Reports Q2 2025 Financial Results and Strategic Review
1M ago
EPI
EPIX
EPIX Lawsuit Alert! Class Action Lawsuit Against ESSA Pharma, Inc.
PremiumMarket News
EPIX Lawsuit Alert! Class Action Lawsuit Against ESSA Pharma, Inc.
3M ago
EPIX
ESSA Pharma Inc. Explores Strategic Options Amid Losses
PremiumCompany Announcements
ESSA Pharma Inc. Explores Strategic Options Amid Losses
4M ago
EPIX
ESSA Pharma Reports Q1 Loss, Explores Strategic Options
PremiumCompany Announcements
ESSA Pharma Reports Q1 Loss, Explores Strategic Options
4M ago
EPI
EPIX
Essa Pharma reports Q4 EPS (19c) vs. (14c) last year
PremiumThe FlyEssa Pharma reports Q4 EPS (19c) vs. (14c) last year
4M ago
EPIX
ESSA Pharma Inc. (EPIX) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
ESSA Pharma Inc. (EPIX) Q1 Earnings Cheat Sheet
4M ago
EPIX
ESSA Pharma Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky LLP Before March 25, 2025 to Discuss Your Rights – EPIX
Premium
Class Action
ESSA Pharma Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky LLP Before March 25, 2025 to Discuss Your Rights – EPIX
4M ago
EPIX
ESSA Pharma’s Cash Management: A Potential Risk to Shareholder Value and Market Stability
PremiumCompany Announcements
ESSA Pharma’s Cash Management: A Potential Risk to Shareholder Value and Market Stability
6M ago
EPIX
ESSA Pharma Inc. Reports Strategic Shift Amid Losses
PremiumCompany Announcements
ESSA Pharma Inc. Reports Strategic Shift Amid Losses
6M ago
EPIX
Essa Pharma reports Q4 EPS (14c), consensus (27c)
PremiumThe Fly
Essa Pharma reports Q4 EPS (14c), consensus (27c)
6M ago
EPIX
EPIX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
EPIX Earnings this Week: How Will it Perform?
6M ago
EPIX
ESSA Pharma Introduces New Executive Severance Plan
PremiumCompany AnnouncementsESSA Pharma Introduces New Executive Severance Plan
6M ago
8K
EPIX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
NVO
VIR
Essa Pharma downgraded to Neutral from Overweight at Piper Sandler
Premium
The Fly
Essa Pharma downgraded to Neutral from Overweight at Piper Sandler
7M ago
EPIX
Essa Pharma downgraded to Perform from Outperform at Oppenheimer
PremiumThe Fly
Essa Pharma downgraded to Perform from Outperform at Oppenheimer
7M ago
EPIX
Essa Pharma downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Essa Pharma downgraded to Hold from Buy at Jefferies
7M ago
EPIX
Essa Pharma downgraded to Hold from Buy at JonesResearch
PremiumThe Fly
Essa Pharma downgraded to Hold from Buy at JonesResearch
7M ago
EPIX
Essa Pharma terminates Phase 2 study of masofaniten combo in mCRPC
PremiumThe Fly
Essa Pharma terminates Phase 2 study of masofaniten combo in mCRPC
7M ago
EPIX
Essa Pharma presents updated updated Phase 1/2 masofaniten data at ESMO
PremiumThe FlyEssa Pharma presents updated updated Phase 1/2 masofaniten data at ESMO
9M ago
EPIX
Premium
Company Announcements
ESSA Pharma Advances Prostate Cancer Clinical Trials
10M ago
EPI
EPIX
Essa Pharma reports Q3 EPS (16c), consensus (25c)
Premium
The Fly
Essa Pharma reports Q3 EPS (16c), consensus (25c)
10M ago
EPIX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >